Showing 19,861 - 19,880 results of 104,281 for search '(( 2 fold decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 2.07s Refine Results
  1. 19861

    VEGF reduces miR-30b expression in HUVECs. by Grant A. Howe (2558611)

    Published 2017
    “…A statistically significant decrease in miR-30b expression is observed following VEGF stimulation. ** <i>P</i> = 0.0024 vs. miR-103; * <i>P</i> = 0.014 vs. …”
  2. 19862

    Demonstration of a Direct Interaction between β<sub>2 - Figure 1 </sub>-Adrenergic Receptor and Insulin Receptor by BRET and Bioinformatics by Maja Mandić (662591)

    Published 2014
    “…<b>(A)</b> ELISA was performed on intact HEK-293 cells transiently transfected with HA-β<sub>2</sub>AR-RLuc8 alone (open bars) or HA-β<sub>2</sub>AR-RLuc8 together with IR-GFP<sup>2</sup> (hatched bars) at a 1∶1 cDNA ratio using an antibody directed against the HA epitope. …”
  3. 19863

    Comparison of RPA2 dynamics in WT, <i>Cdk2</i><sup><i>T160A</i></sup>, <i>and Cdk2</i><sup><i>−/−</i></sup> spermatocytes. by Nathan Palmer (264897)

    Published 2020
    “…<p>P40 chromosome spread preparations immunostained for RPA2 (green) and SYCP3 (red) are shown for WT (A–D), <i>Cdk2</i><sup><i>T160A</i></sup> spermatocytes (E–H), and <i>Cdk2</i><sup><i>−/−</i></sup> (I–K) for selected stages of meiotic prophase I. …”
  4. 19864
  5. 19865
  6. 19866

    Effects of RcsB, LrhA, RtsB and SlyA on transcription of P1<i><sub>flhDC</sub></i> and P5<i><sub>flhDC</sub></i>. by Chakib Mouslim (531364)

    Published 2014
    “…Luciferase activity of P5<sup>−</sup><i><sub>fhlDC</sub>-luxCDBAE-</i>Pwt<i><sub>flhDC</sub>flhD</i><sup>+</sup><i>C</i><sup>+</sup> transcriptional fusion (P1-expressed) was investigated in five genetic backgrounds: wild-type (TH18895), Δ<i>rcsB</i>::<i>tetRA</i> (TH20237), <i>rtsB</i>::T-POP (TH19976), Δ<i>lrhA</i>::<i>tetRA</i> (TH19974), <i>slyA</i>::T-POP (TH19975). …”
  7. 19867
  8. 19868
  9. 19869
  10. 19870

    Impact of Lombard effect in NPVH (Castro et al., 2022) by Christian Castro (7525315)

    Published 2022
    “…</p> <p><br></p> <p><strong>Table S2.</strong> Mean values and standard deviations for SPL-normalized measures.…”
  11. 19871
  12. 19872

    Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  13. 19873

    Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  14. 19874

    Table 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  15. 19875

    5-HI stimulates GI motility in vivo. by Barbora Waclawiková (10024630)

    Published 2021
    “…After treatment, TGTT was significantly decreased in WTG rats treated with 30 mg/kg of 5-HI (black circles, <i>n</i> = 10; red circles show single measurement points in each rat before and after treatment) but not in the vehicle group treated with 10% sucrose (black squares, <i>n</i> = 6; gray squares show single measurement points in each rat before and after treatment). …”
  16. 19876

    Design of a RSSCA system for agriculture. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…<div><p>Agricultural land is increasingly under pressure from expanding solar energy infrastructure, leading to a growing conflict between food and energy production. …”
  17. 19877

    Venn diagram representing the RNA sequencing results. by Shyamasree De Majumdar (168216)

    Published 2015
    “…The arrows ⬇ indicates a lower than 0.5 fold decrease in transcription compared to calibrator; ⬆ indicates a higher than 2 fold transcription compared to calibrator. …”
  18. 19878

    Triiodide-Induced Band-Edge Reconstruction of a Lead-Free Perovskite-Derivative Hybrid for Strong Light Absorption by Weichuan Zhang (3956327)

    Published 2018
    “…However, most of the known lead-free hybrids show wide band gaps (<i>E</i><sub>g</sub> > 1.9 eV) that afford weak visible-light absorption. Here, we show a newly conceptual design strategy of intercalating triiodide to decrease the prototypic band gap by ca. ∼0.44 eV. …”
  19. 19879
  20. 19880